Deferoxamine

Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine

Sudha R. Vippagunta, Arnulf Dorn, André Bubendorf, Robert G. Ridley, Jonathan L Vennerstrom

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The iron chelator deferoxamine enhances the clearance of Plasmodium falciparum parasitemia and may be useful in drug combinations for the treatment of cerebral malaria. However, the deferoxamine-chloroquine drug combination is antagonistic, or at best additive, against P. falciparum in vitro. As chloroquine is thought to exert its antimalarial activity by interacting with hematin released from the proteolytic degradation of hemoglobin in the parasite food vacuole, we hypothesized that deferoxamine might interfere with the ability of chloroquine to inhibit hematin polymerization, since it was reported that deferoxamine interacts with hematin. Therefore, we assessed deferoxamine-hematin binding in more detail and investigated the effect of deferoxamine on hematin polymerization in the presence and absence of chloroquine. Isothermal titration calorimetry (ITC) experiments demonstrated an enthalpy-driven deferoxamine:hematin μ-oxo dimer binding with an association constant of 2.8 x 104 M-1 at pH 6.5, a binding affinity 14-fold lower than that measured for chloroquine. At least two of the three hydroxamic acid functional groups of deferoxamine must be unionized for effective binding. We also discovered that deferoxamine antagonized chloroquine-mediated inhibition of hematin polymerization. Unexpectedly, deferoxamine increased the concentration of soluble forms of hematin and enhanced the rate of hematin polymerization. Deferoxamine also could initiate hematin polymerization. In contrast, chloroquine decreased the concentration of soluble forms of hematin and inhibited hematin polymerization. This work supports the postulate that initiation of hematin polymerization requires a higher concentration of soluble hematin monomer than does the elongation phase of polymerization and provides one possible explanation for the observed antagonism between deferoxamine and chloroquine against parasites in culture. Copyright (C) 1999 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)817-824
Number of pages8
JournalBiochemical Pharmacology
Volume58
Issue number5
DOIs
StatePublished - Sep 1 1999

Fingerprint

Hemin
Deferoxamine
Chloroquine
Polymerization
Drug Combinations
Plasmodium falciparum
Parasites
Hydroxamic Acids
Cerebral Malaria
Calorimetry
Parasitemia
Antimalarials
Chelating Agents
Vacuoles
Titration
Dimers
Functional groups

Keywords

  • Association constant
  • Chloroquine
  • Deferoxamine
  • Hematin polymerization
  • Hematin μ-oxo dimer
  • Malaria

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Deferoxamine : Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. / Vippagunta, Sudha R.; Dorn, Arnulf; Bubendorf, André; Ridley, Robert G.; Vennerstrom, Jonathan L.

In: Biochemical Pharmacology, Vol. 58, No. 5, 01.09.1999, p. 817-824.

Research output: Contribution to journalArticle

Vippagunta, Sudha R. ; Dorn, Arnulf ; Bubendorf, André ; Ridley, Robert G. ; Vennerstrom, Jonathan L. / Deferoxamine : Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine. In: Biochemical Pharmacology. 1999 ; Vol. 58, No. 5. pp. 817-824.
@article{f006539b9e6b4a508220c26310c3d84c,
title = "Deferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine",
abstract = "The iron chelator deferoxamine enhances the clearance of Plasmodium falciparum parasitemia and may be useful in drug combinations for the treatment of cerebral malaria. However, the deferoxamine-chloroquine drug combination is antagonistic, or at best additive, against P. falciparum in vitro. As chloroquine is thought to exert its antimalarial activity by interacting with hematin released from the proteolytic degradation of hemoglobin in the parasite food vacuole, we hypothesized that deferoxamine might interfere with the ability of chloroquine to inhibit hematin polymerization, since it was reported that deferoxamine interacts with hematin. Therefore, we assessed deferoxamine-hematin binding in more detail and investigated the effect of deferoxamine on hematin polymerization in the presence and absence of chloroquine. Isothermal titration calorimetry (ITC) experiments demonstrated an enthalpy-driven deferoxamine:hematin μ-oxo dimer binding with an association constant of 2.8 x 104 M-1 at pH 6.5, a binding affinity 14-fold lower than that measured for chloroquine. At least two of the three hydroxamic acid functional groups of deferoxamine must be unionized for effective binding. We also discovered that deferoxamine antagonized chloroquine-mediated inhibition of hematin polymerization. Unexpectedly, deferoxamine increased the concentration of soluble forms of hematin and enhanced the rate of hematin polymerization. Deferoxamine also could initiate hematin polymerization. In contrast, chloroquine decreased the concentration of soluble forms of hematin and inhibited hematin polymerization. This work supports the postulate that initiation of hematin polymerization requires a higher concentration of soluble hematin monomer than does the elongation phase of polymerization and provides one possible explanation for the observed antagonism between deferoxamine and chloroquine against parasites in culture. Copyright (C) 1999 Elsevier Science Inc.",
keywords = "Association constant, Chloroquine, Deferoxamine, Hematin polymerization, Hematin μ-oxo dimer, Malaria",
author = "Vippagunta, {Sudha R.} and Arnulf Dorn and Andr{\'e} Bubendorf and Ridley, {Robert G.} and Vennerstrom, {Jonathan L}",
year = "1999",
month = "9",
day = "1",
doi = "10.1016/S0006-2952(99)00161-6",
language = "English (US)",
volume = "58",
pages = "817--824",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Deferoxamine

T2 - Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine

AU - Vippagunta, Sudha R.

AU - Dorn, Arnulf

AU - Bubendorf, André

AU - Ridley, Robert G.

AU - Vennerstrom, Jonathan L

PY - 1999/9/1

Y1 - 1999/9/1

N2 - The iron chelator deferoxamine enhances the clearance of Plasmodium falciparum parasitemia and may be useful in drug combinations for the treatment of cerebral malaria. However, the deferoxamine-chloroquine drug combination is antagonistic, or at best additive, against P. falciparum in vitro. As chloroquine is thought to exert its antimalarial activity by interacting with hematin released from the proteolytic degradation of hemoglobin in the parasite food vacuole, we hypothesized that deferoxamine might interfere with the ability of chloroquine to inhibit hematin polymerization, since it was reported that deferoxamine interacts with hematin. Therefore, we assessed deferoxamine-hematin binding in more detail and investigated the effect of deferoxamine on hematin polymerization in the presence and absence of chloroquine. Isothermal titration calorimetry (ITC) experiments demonstrated an enthalpy-driven deferoxamine:hematin μ-oxo dimer binding with an association constant of 2.8 x 104 M-1 at pH 6.5, a binding affinity 14-fold lower than that measured for chloroquine. At least two of the three hydroxamic acid functional groups of deferoxamine must be unionized for effective binding. We also discovered that deferoxamine antagonized chloroquine-mediated inhibition of hematin polymerization. Unexpectedly, deferoxamine increased the concentration of soluble forms of hematin and enhanced the rate of hematin polymerization. Deferoxamine also could initiate hematin polymerization. In contrast, chloroquine decreased the concentration of soluble forms of hematin and inhibited hematin polymerization. This work supports the postulate that initiation of hematin polymerization requires a higher concentration of soluble hematin monomer than does the elongation phase of polymerization and provides one possible explanation for the observed antagonism between deferoxamine and chloroquine against parasites in culture. Copyright (C) 1999 Elsevier Science Inc.

AB - The iron chelator deferoxamine enhances the clearance of Plasmodium falciparum parasitemia and may be useful in drug combinations for the treatment of cerebral malaria. However, the deferoxamine-chloroquine drug combination is antagonistic, or at best additive, against P. falciparum in vitro. As chloroquine is thought to exert its antimalarial activity by interacting with hematin released from the proteolytic degradation of hemoglobin in the parasite food vacuole, we hypothesized that deferoxamine might interfere with the ability of chloroquine to inhibit hematin polymerization, since it was reported that deferoxamine interacts with hematin. Therefore, we assessed deferoxamine-hematin binding in more detail and investigated the effect of deferoxamine on hematin polymerization in the presence and absence of chloroquine. Isothermal titration calorimetry (ITC) experiments demonstrated an enthalpy-driven deferoxamine:hematin μ-oxo dimer binding with an association constant of 2.8 x 104 M-1 at pH 6.5, a binding affinity 14-fold lower than that measured for chloroquine. At least two of the three hydroxamic acid functional groups of deferoxamine must be unionized for effective binding. We also discovered that deferoxamine antagonized chloroquine-mediated inhibition of hematin polymerization. Unexpectedly, deferoxamine increased the concentration of soluble forms of hematin and enhanced the rate of hematin polymerization. Deferoxamine also could initiate hematin polymerization. In contrast, chloroquine decreased the concentration of soluble forms of hematin and inhibited hematin polymerization. This work supports the postulate that initiation of hematin polymerization requires a higher concentration of soluble hematin monomer than does the elongation phase of polymerization and provides one possible explanation for the observed antagonism between deferoxamine and chloroquine against parasites in culture. Copyright (C) 1999 Elsevier Science Inc.

KW - Association constant

KW - Chloroquine

KW - Deferoxamine

KW - Hematin polymerization

KW - Hematin μ-oxo dimer

KW - Malaria

UR - http://www.scopus.com/inward/record.url?scp=0032770944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032770944&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(99)00161-6

DO - 10.1016/S0006-2952(99)00161-6

M3 - Article

VL - 58

SP - 817

EP - 824

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 5

ER -